Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine

This article provides an overview of the efforts of the U.S. Food and Drug Administration (FDA) to facilitate product development in the field commonly known was regenerative medicine. It provides an introduction to the processes by which FDA works with individual sponsors, interacts with the scientific and industry communities, participates in standards development, and develops formal FDA policy and guidance.

Source: Stem Cells Translational Medicine - December 10, 2015 Category: Stem Cells Authors: Witten, C. M., McFarland, R. D., Simek, S. L. Tags: Concise Review, Tissue Engineering and Regenerative Medicine Source Type: research